Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 5Lung Neoplasms 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Recurrence 2Neoplasm Metastasis 2Malignant Neoplasms of Independent (Primary) Multiple Sites 2Lung Diseases 2Head and Neck Neoplasms 2cyclopia sequence 1Tobacco Use Cessation 1Smoke Inhalation Injury 1Sezary Syndrome 1Seroma 1Sarcoma 1Respiratory Aspiration 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyneuropathies 1Peripheral Nervous System Diseases 1Patient Education 1Pain 1Ovarian Neoplasms 1Occupational Stress 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Mouth Neoplasms 1Mesothelioma 1Malignant Neoplasms of Female Genital Organs 1Lymphoma, T-Cell, Cutaneous 1

Interventions

dolutegravir 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Ritonavir 1Nucleosides 1Darunavir 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Acquired Immunodeficiency Syndrome × Surveys and Questionnaires × Clear all
NCT02029612 2014-02-28

An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy)

M.D. Anderson Cancer Center

Phase NA Withdrawn

Acquired Immunodeficiency Syndrome, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡